{"transactions":[{"id":952490,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":70394,"kind":"person","name":"Mayer Arie","position":1,"cik":"0001796583","reported_name":"Mayer Arie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-05T22:20:05.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":4900,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs. The RSUs will vest in quarterly installments over a one-year period starting April 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents RSUs. The RSUs will vest in quarterly installments over a one-year period starting April 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer."}],"balance_after":168009,"source":{"system":"sec-edgar","filing":"0001213900-26-001275","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390026001275/ownership.xml","form_type":"4"}},{"id":952489,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":70394,"kind":"person","name":"Mayer Arie","position":1,"cik":"0001796583","reported_name":"Mayer Arie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-05T22:20:05.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). The RSUs will vest ratably in three annual tranches beginning January 1, 2027. Each RSU represents the right to receive one share of common stock, par value $0.012 per share (\"Common Stock\"), of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). The RSUs will vest ratably in three annual tranches beginning January 1, 2027. Each RSU represents the right to receive one share of common stock, par value $0.012 per share (\"Common Stock\"), of the Issuer."}],"balance_after":163109,"source":{"system":"sec-edgar","filing":"0001213900-26-001275","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390026001275/ownership.xml","form_type":"4"}},{"id":1118369,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":70394,"kind":"person","name":"Mayer Arie","position":1,"cik":"0001796583","reported_name":"Mayer Arie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T20:08:35.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":6975,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents RSUs that will vest in equal installments as follows: on grant, July 1, 2025, October 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":133109,"source":{"system":"sec-edgar","filing":"0001213900-25-052624","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025052624/ownership.xml","form_type":"4"}},{"id":1118368,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":70394,"kind":"person","name":"Mayer Arie","position":1,"cik":"0001796583","reported_name":"Mayer Arie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T20:08:35.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in equal portions of 10,000 as follows: January 1, 2026, January 1, 2027 and January 1, 2028. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":126134,"source":{"system":"sec-edgar","filing":"0001213900-25-052624","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025052624/ownership.xml","form_type":"4"}},{"id":1684515,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":70394,"kind":"person","name":"Mayer Arie","position":1,"cik":"0001796583","reported_name":"Mayer Arie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-08T21:34:53.000Z","date":"2024-01-04","kind":"grant","planned":false,"acquired":true,"shares":9325,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in quarterly installments of approximately 2,331 on April 1, 2024, July  1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":96134,"source":{"system":"sec-edgar","filing":"0001209191-24-001137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919124001137/doc4.xml","form_type":"4"}},{"id":1684514,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":70394,"kind":"person","name":"Mayer Arie","position":1,"cik":"0001796583","reported_name":"Mayer Arie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-08T21:34:53.000Z","date":"2024-01-04","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2025, January 1, 2026 and January 1, 2027. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":86809,"source":{"system":"sec-edgar","filing":"0001209191-24-001137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919124001137/doc4.xml","form_type":"4"}},{"id":1916595,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":70394,"kind":"person","name":"Mayer Arie","position":1,"cik":"0001796583","reported_name":"Mayer Arie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-20T10:00:14.000Z","date":"2023-04-17","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in equal quarterly installments of 2,500 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":56809,"source":{"system":"sec-edgar","filing":"0001209191-23-024935","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919123024935/doc4.xml","form_type":"4"}},{"id":1929152,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":70394,"kind":"person","name":"Mayer Arie","position":1,"cik":"0001796583","reported_name":"Mayer Arie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T21:10:06.000Z","date":"2023-04-04","kind":"purchase","planned":false,"acquired":true,"shares":3800,"price":2.21,"value":8398.0,"ownership":{"direct":true},"balance_after":26809,"source":{"system":"sec-edgar","filing":"0001209191-23-022815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919123022815/doc4.xml","form_type":"4"}},{"id":1929151,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":70394,"kind":"person","name":"Mayer Arie","position":1,"cik":"0001796583","reported_name":"Mayer Arie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T21:10:06.000Z","date":"2023-04-03","kind":"purchase","planned":false,"acquired":true,"shares":5009,"price":2.22,"value":11119.98,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.17 to $2.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range."}],"balance_after":23009,"source":{"system":"sec-edgar","filing":"0001209191-23-022815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919123022815/doc4.xml","form_type":"4"}},{"id":2199220,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":70394,"kind":"person","name":"Mayer Arie","position":1,"cik":"0001796583","reported_name":"Mayer Arie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T00:01:14.000Z","date":"2022-07-28","kind":"grant","acquired":true,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in 3 installments as follows: 4,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001209191-22-043771","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919122043771/doc4.xml","form_type":"4"}},{"id":2276424,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":70394,"kind":"person","name":"Mayer Arie","position":1,"cik":"0001796583","reported_name":"Mayer Arie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-10T21:32:32.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amendment is being filed to correct an administrative error in the Form 4 filed by Dr. Mayer, which reported that 9,000 shares of common stock were beneficially owned by him following the reported transaction. Dr. Mayer beneficially owned 6,000 shares of common stock following the reported transaction."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001213900-22-025289","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022025289/ownership.xml","form_type":"4/A","original_submission_date":"2022-01-05"}},{"id":2276422,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":70394,"kind":"person","name":"Mayer Arie","position":1,"cik":"0001796583","reported_name":"Mayer Arie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-10T21:30:17.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":3000,"price":25.6,"value":76800.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-22-025288","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022025288/ownership.xml","form_type":"4"}},{"id":2444641,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":70394,"kind":"person","name":"Mayer Arie","position":1,"cik":"0001796583","reported_name":"Mayer Arie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T01:51:10.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option will vest in 4 installments as follows: 2,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026."}],"balance_after":10000,"derivative":{"exercise_price":13.89,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-22-000820","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022000820/ownership.xml","form_type":"4"}},{"id":2444640,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":70394,"kind":"person","name":"Mayer Arie","position":1,"cik":"0001796583","reported_name":"Mayer Arie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-06T01:51:10.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001213900-22-000820","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022000820/ownership.xml","form_type":"4"}},{"id":3311785,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":70394,"kind":"person","name":"Mayer Arie","position":1,"cik":"0001796583","reported_name":"Mayer Arie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-14T21:06:52.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in 3 installments as follows: 6,666 shall vest on December 31, 2020; and 6,667 shall vest on each of December 31, 2021 and December 31, 2022."}],"balance_after":20000,"derivative":{"exercise_price":4.8,"expiration_date":"2030-01-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-20-000989","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390020000989/ownership.xml","form_type":"4"}}]}